Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Hyperbaric Oxygen in the Treatment of Sudden Hearing Loss (CROSBI ID 238207)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Račić, Goran ; Maslovara, Siniša ; Roje, Željka ; Đogaš, Zoran ; Tafra, Robert Hyperbaric Oxygen in the Treatment of Sudden Hearing Loss // ORL, 65 (2003), 6; 317-320. doi: 10.1159/000076048

Podaci o odgovornosti

Račić, Goran ; Maslovara, Siniša ; Roje, Željka ; Đogaš, Zoran ; Tafra, Robert

engleski

Hyperbaric Oxygen in the Treatment of Sudden Hearing Loss

Treatment of idiopathic sudden hearing loss (SHL) is still a great problem for the physicians, due to the still unexplained etiopathogenesis of the disease. This retrospective study includes 115 patients with idiopathic SHL and compares two therapy regimens. Of the total number of patients, 51 had been primarily treated by hyperbaric oxygen (HBO) at 2.8 bar. The remaining 64 patients had been treated by pentoxifylline infusions in increasing and decreasing doses. Hearing thresholds were ascertained at the frequencies of 250, 500, 1, 000, 2, 000 and 4, 000 Hz using pure-tone audiometry. The results after treatment showed a statistically significant improvement of hearing by 46.35 (SD +/-18.58) dB hearing level (HL) in the group of patients treated with HBO, compared with an improvement of hearing by 21.48 dB HL (SD +/-13.5) in the group of patients treated with pentoxifylline infusions (p < 0.001). Furthermore, hearing recovered to physiological values in 24 of 51 (47.1%) HBO-treated patients, compared to only 4 of 64 (6.2%) of the pentoxifylline-treated patients. Furthermore, after pentoxifylline treatment only 8/64 (12.5%) patients showed partial recovery, whereas after HBO therapy 21/51 (41.2%) patients improved up to a mild persistent hearing loss. This indicates strong evidence that HBO therapy is more effective in the treatment of idiopathic SHL than conventional rheological treatment. However, more prospective clinical trials should confirm the efficiency of HBO therapy and lead to its wider application.

Hearing loss, Sudden deafness, Pentoxifylline, Hyperbaric oxygenation

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

ORL

65 (6)

2003.

317-320

objavljeno

0301-1569

10.1159/000076048

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost